Global Drug Discovery and Development Industry
The global drug discovery and development industry (part of the widerpharmaceutical industry) involves the discovery and design of drugs through laboratory testing to treat disease and infection.With costs running high and few drugs making it to the market,drug discovery and development leaders are constantly seeking ways to reduce expenditure and boost efficiency.
One option companies frequently avail of is the practice of outsourcing sections of the discovery and development process.The global drug discovery outsourcing market is expected to grow from less than $7.5 billion in 2009 to a forecast worth of $18.5 billion in 2015,according to Business Insights.Meanwhile,the global drug discovery technologies market is expected to be worth more than $32 billion by 2012,growing at an annual compound rate in excess of 8%.
The industry requires heavy investment with no guarantee of results,including under 1% of discoveries going on to be approved by the US Food and Drug Administration.The process itself can take between 12 and 20 years,and cost over the $1.2 billion mark,reports theAlfred Mann Foundation for Biomedical Engineering.
Leading Market Segments
It is estimated that high throughput screening will be worth $12 billion by 2012,showing over 7% growth in the preceding five years.
Bioanalytical instruments have a forecast worth of $10.5 billion in 2012,demonstrating growth in excess of 9%.It is believed the segment of other technologies should come close to the $4.5 billion mark in 2012.Business Insights estimates the electronic data capturemarket for clinical trialswill pass the $1 billion mark in 2016 at 13% annual growth.
Process: Drug Testing and Development
The steps involved in drug discovery begin with the identification of targets,which are genetic or cellular chemicals that influence disease.Once the target has been isolated,the compounds that may work best on them can in turn be determined.Next,the chosen target's capacity to act on diseased cells is observed before compounds necessary to create a drug are determined,along with the drug target's response to the compound.In the next phase compounds are compared and data is compiled to aid biopharmaceutical companies to determine the most promising compound for drug creation.
Once a drug has been designed,it enters the preclinical phase of development in which it is tested for up to five years to establish its impact on cells.The drug also undergoes toxicology testing to determine any possible harm to humans.In the clinical phase,drugs are administered to humans to test efficacy and potential side effects before companies seek authorization to market the new drug.Researchcompiled throughout the process is submitted to the relevant authority as the company awaits approval;this part of the process can last up to two years.